FindTrial
Sign In

A TRIAL COMPARING EFFECTIVENESS OF TWO MANEUVERS FOR TREATMENT OF SUDDEN AND ABNORMALLY INCREASED HEART RATE

A RANDOMIZED TRIAL OF MODIFIED VALSALVA VERSUS STANDARD VALSALVA MANEUVER FOR CARDIOVERSION IN PATIENTS WITH SUPRAVENTRICULAR TACHYCARDIA IN EMERGENCY DEPARTMENT

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030684
Enrollment
96
Registered
2021-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I471- Supraventricular tachycardia

Interventions

Intervention1: Modified Valsalva Maneuver: MODIFIED Valsava Maneuver (INTERVENTION): Participants will be seated at a 45° angle, and will perform the standardized strain for 15 s. Following this, the

Sponsors

Department of Emergency Medicine
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients/Legally Authorized Representative(LAR) providing Informed consent 2. Diagnosis of supraventricular tachycardia (SVT; regular, narrow complex tachycardia with QRS duration <0.12 s on ECG with absent or overt p wave)

Exclusion criteria

Exclusion criteria: I. Unable or unwilling to give informed consent II. Unstable condition (systolic blood pressure (BP) III. Atrial fibrillation/atrial flutter/sinus tachycardia/MAT on ECG IV. Systemic hypoperfusion i. Altered mentation ii. Chest pain (due to coronary ischemia) iii. Dyspnea (due to pulmonary edema) V. Severe hypertension (systolic BP >220 mm Hg or diastolic BP >120 mm Hg) VI. Any contraindication to or inability to performing a Valsalva maneuver VII. Contraindication or inability to lay flat and have legs lifted (or any reason identified by the patient as to why this maneuver would cause discomfort or pain) VIII. Pregnancy IX. Myocardial Infarction( X. Known case of glaucoma or retinopathy XI. Previous inclusion in the study

Design outcomes

Primary

MeasureTime frame
Cardioversion in Patients with supraventricular tachycardia(achievement of normal sinus rhythm on electrocardiography after standard/modified valsalva maneuver)Timepoint: 1 minute—

Secondary

MeasureTime frame
â??To compare sustained success rates at the third and fifth minute of application of the maneuver in each arm â?? Failure to revert SVT to a sinus rhythm, followed by: i) repeated attempts at Standard or Modified Valsalva Maneuver ii) pharmacological intervention; or iii) direct current countershock therapies. â?? To compare frequency and severity of adverse events resulting from application of maneuversTimepoint: 3, 5 minutes—

Countries

India

Contacts

Public ContactDr Sheena Arora

All India Institute of Medical Sciences, New Delhi

peekay_124@outlook.in

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026